China SXT Pharmaceuticals(SXTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SXTC China SXT Pharmaceuticals

Trading 07-27 12:50:32 EDT

0.0663

+0.0025

+3.92%

High0.0810	Low0.0610	Vol313.52M
Open0.0650	D1 Closing0.0638	Amplitude31.35%
Mkt Cap2.53M	Tradable Cap2.52M	Total Shares38.22M
T/O22.24M	T/O Rate826.24%	Tradable Shares37.94M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SXTC","market":"US","secType":"STK","nameCN":"China SXT Pharmaceuticals","latestPrice":0.0663,"timestamp":1785171026324,"preClose":0.0638,"halted":0,"volume":313515946,"delay":0,"changeRate":0.039184952978056464,"floatShares":37944871,"shares":38218077,"eps":-9.129851,"marketStatus":"Trading","change":0.0025,"latestTime":"07-27 12:50:32 EDT","open":0.065,"high":0.081,"low":0.061,"amount":22242721.115872763,"amplitude":0.31348,"askPrice":0.0663,"askSize":100,"bidPrice":0.0662,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-9.129851,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1785182400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1546578000000,"exchange":"NASDAQ","adjPreClose":0.0638,"preHourTrading":{"tag":"盘前","latestPrice":0.0641,"preClose":0.0638,"latestTime":"09:29 EDT","volume":153680244,"amount":12434720.36195736,"timestamp":1785158997091,"change":0.0003,"changeRate":0.004702,"amplitude":0.929467},"postHourTrading":{"tag":"盘后","latestPrice":0.0869,"preClose":0.0638,"latestTime":"19:59 EDT","volume":101291531,"amount":8131409.062156,"timestamp":1784937599487,"change":0.0231,"changeRate":0.362069,"amplitude":0.626959},"volumeRatio":7.333091},"requestUrl":"/m/hq/s/SXTC","defaultTab":"news","newsList":[{"id":"2654370010","title":"Univest Securities, Llc Announces Closing of $9 Million Registered Direct Offering for Its Client China SXT Pharmaceuticals Inc. (nasdaq: Sxtc)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654370010","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654370010?lang=en_us&edition=fundamental","pubTime":"2026-07-25 05:30","pubTimestamp":1784928600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nTUAC3LBGJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654303771","title":"China SXT Pharmaceuticals Raises $9 Million in Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2654303771","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654303771?lang=en_us&edition=fundamental","pubTime":"2026-07-25 04:55","pubTimestamp":1784926558,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals ( ($SXTC) ) has shared an update. On July 23, 2026, China SXT Pharmaceuticals, Inc. entered into a securities purchase ag...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/china-sxt-pharmaceuticals-raises-9-million-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/china-sxt-pharmaceuticals-raises-9-million-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTC","BK4007","PSCM","BK4109","SXT","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653714035","title":"U.S. Stocks on the Move-booz Allen Hamilton, Sensient, Amkor","url":"https://stock-news.laohu8.com/highlight/detail?id=2653714035","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653714035?lang=en_us&edition=fundamental","pubTime":"2026-07-24 23:50","pubTimestamp":1784908259,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, AmkorWorkspace search string for individual stock moves:STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsle","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nL6N43Q10Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXP","SCTX","SXT","SNDK","COHR","BAH","OMH","SXTC","SAFT","CHPS","IXN","FAI","FFAI","RITA","CLSE","MNKD","SMMT","TYLG","WNDR","VDE","ZVRA","COHH","LVWR","CHRW","RNG","IPAY","THC","BW","COHX","HIMS","INTC","RNTY","COWG","DLR","SLB","NVD3.UK","GDDY","VZ","DECK","SNPE","CDXS","ABFL","NVDA","SNDC","BRCC","2NVD.UK","AMKR","AU","NEM","IEZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653081426","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2653081426","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653081426?lang=en_us&edition=fundamental","pubTime":"2026-07-24 19:43","pubTimestamp":1784893424,"startTime":"0","endTime":"0","summary":"VYNE Therapeutics  shares were down 41% in Friday premarket trading  as the company's 1-for-50 reverse stock split is expected to become effective, with the shares to begin trading on a post-split basis on Monday.China SXT Pharmaceuticals  stock was down 27% after the company entered into a definitive securities purchase agreement for a registered direct offering of 4.5 million units at $2.00 per unit.Codexis  shares were down 26% after the company priced an underwritten public offering of about 16.7 million common shares at $1.50 per share.TDH  stock was down 19%, reversing the previous session's 13% decline.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VYNE","SXTC","BK4212","BK4121","PETZ","BK4233","BK4007","CDXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653672315","title":"China SXT Pharmaceuticals prices 4.5M units at $2.00 in registered direct offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2653672315","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653672315?lang=en_us&edition=fundamental","pubTime":"2026-07-23 21:11","pubTimestamp":1784812269,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals (SXTC) announced that it has entered into a definitive securities purchase agreement with certain institutional investors...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/china-sxt-pharmaceuticals-prices-4-5m-units-at-2-00-in-registered-direct-offer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/china-sxt-pharmaceuticals-prices-4-5m-units-at-2-00-in-registered-direct-offer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","IE0009354923.USD","SXT","BK4007","PSCM","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653728515","title":"China SXT Pharmaceuticals Issues Warrants in USD 9 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2653728515","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653728515?lang=en_us&edition=fundamental","pubTime":"2026-07-23 20:45","pubTimestamp":1784810722,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals issues warrants in USD 9 million registered direct offeringChina SXT Pharmaceuticals launched a registered direct offering of 4,500,000 units at USD 2 per unit for about USD ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL1L1tMB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BCDF","SG9999014021.USD","IE00B64PRP62.GBP","SG9999014005.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014039.USD","BK4112","BK4585","IE00BGHQF748.EUR","SG9999014013.SGD","BK4007","NDAQ","IE00BN0W2W23.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4588","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653440137","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2653440137","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653440137?lang=en_us&edition=fundamental","pubTime":"2026-07-23 19:24","pubTimestamp":1784805887,"startTime":"0","endTime":"0","summary":"Leslie's  shares were down 38% in Thursday premarket trading, following the previous session's 1.3% gain.Zhongchao  stock was down 32% after the Wednesday session's 192% rally.China SXT Pharmaceuticals  shares were down 22%, extending the previous session's nearly 25% decline.Wheeler Real Estate Investment Trust  stock was down 20%, adding to the earlier session's 1.3% loss.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LESL","WHLR","BK4200","BK4007","ZCMD","BK4204","BK4080","SXTC","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653775474","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2653775474","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653775474?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:04","pubTimestamp":1784718274,"startTime":"0","endTime":"0","summary":"INLIF  shares were up 89% in recent Wednesday premarket activity, recovering from a 3% loss in the previous session.China SXT Pharmaceuticals  stock was up 61%, adding to a 9% gain in the earlier session.Core AI  shares were 67% higher after the company said it is positioning its HomeGPT platform as an AI-powered residential decision layer.Antelope Enterprise  stock was 38% higher, rebounding from a 2.6% loss in the Tuesday session.Super Micro Computer  shares were up 17% after the company said it expects Q4 gross margins of 15% to 17%, while multiple firms raised their price targets on the stock.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1861215975.USD","SXTC","SMCZ","INLF","BK4543","AEHL","BK4086","BK4020","SMCL","BK4585","BK4170","LU1861220033.SGD","LU0053671581.USD","SMCC","SMCY","BK4007","BK4077","SMYY","BK4161","SMCI","CHAI","SMCX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649958177","title":"China Sxt Pharmaceuticals Files Resale Registration for Up to 157.5 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2649958177","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649958177?lang=en_us&edition=fundamental","pubTime":"2026-07-08 05:39","pubTimestamp":1783460365,"startTime":"0","endTime":"0","summary":"China Sxt Pharmaceuticals  on Tuesday filed a statement to register the resale of up to 157.5 million Class A ordinary shares by selling shareholder Smart Mart.The shares may be issued under a July 3 securities purchase agreement that provides for up to $31.5 million in prepaid purchases.The company said it will not receive any proceeds from the resale of shares by the selling shareholder.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SXTC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649309059","title":"China SXT Pharmaceuticals: Files for Offering of 157.5 Mln Class a Ordinary Shares by Selling Shareholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2649309059","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649309059?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:44","pubTimestamp":1783457041,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nFWN43913B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649717056","title":"China SXT Pharmaceuticals Secures Up to $30 Million in New Pre‑Paid Share Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2649717056","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649717056?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:57","pubTimestamp":1783371462,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals ( ($SXTC) ) has issued an update. On July 3, 2026, China SXT Pharmaceuticals entered into a securities purchase agreement...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/china-sxt-pharmaceuticals-secures-up-to-30-million-in-new-prepaid-share-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/china-sxt-pharmaceuticals-secures-up-to-30-million-in-new-prepaid-share-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","SXT","PSCM","SXTC","BK4007","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648206526","title":"China SXT Pharmaceuticals FY26 Net Loss Widens to $6.21 Million; Revenue Drops 35% to $1.14 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2648206526","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648206526?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:32","pubTimestamp":1782937956,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals FY26 net loss widens to $6.21 million; revenue drops 35% to $1.14 millionChina SXT Pharmaceuticals fiscal 2026 net loss widened 88% to USD 6.21 million as revenue fell 35% to","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDLxS1jG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640671279","title":"China SXT Pharmaceuticals Launches $100 Million ATM Equity Program with Univest Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2640671279","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640671279?lang=en_us&edition=fundamental","pubTime":"2026-06-02 05:35","pubTimestamp":1780349716,"startTime":"0","endTime":"0","summary":"An announcement from China SXT Pharmaceuticals ( ($SXTC) ) is now available. China SXT Pharmaceuticals, Inc. entered into a new at-the-market sales...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/china-sxt-pharmaceuticals-launches-100-million-atm-equity-program-with-univest-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/china-sxt-pharmaceuticals-launches-100-million-atm-equity-program-with-univest-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQR","BK4109","SXTC","BK4585","BK4215","IE0009354923.USD","BK4007","BK4588","SXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640967871","title":"China SXT Pharmaceuticals - to Offer up to $100 Mln of Class a Ordinary Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640967871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640967871?lang=en_us&edition=fundamental","pubTime":"2026-06-02 05:13","pubTimestamp":1780348393,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290RE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640962028","title":"China SXT Pharmaceuticals enters at-the-market equity sales agreement for up to $100 million offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640962028","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640962028?lang=en_us&edition=fundamental","pubTime":"2026-06-02 05:07","pubTimestamp":1780348030,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals set an at-the-market equity program for up to USD 100 million of Class A ordinary shares via Univest Securities.Univest will use commercially reasonable efforts to place shares, with sales expected to occur on Nasdaq or other trading venues.Univest will earn a 3% commission on gross proceeds, with an added USD 0.003 per share trading and exchange fee reimbursement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained ther","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL1qqb4G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633896187","title":"China SXT Pharmaceuticals raises $3.5 million in private placement of shares, warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2633896187","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633896187?lang=en_us&edition=fundamental","pubTime":"2026-05-05 05:01","pubTimestamp":1777928496,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals entered private placement with non-U.S. investors on May 1, 2026, raising gross proceeds of $3.5 million.Deal issued 3,500,000 Class A ordinary shares, no par value, alongside 3,500,000 warrants exercisable at $1 per share.Warrants became exercisable on issuance, expire five years from issuance, include customary anti-dilution adjustments, allow cash or cashless exercise.Offering closed May 2, 2026; net proceeds earmarked for working capital, general corporate purposes.Securities sold in unregistered transaction under Regulation S.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gatherin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL6ZK7j6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630444312","title":"China SXT Pharmaceuticals Co-CEO Simon Lim files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2630444312","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630444312?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:01","pubTimestamp":1777320102,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals filed an initial Form 3 naming Simon Lim Sze Beng as co-chief executive officer.Filing reported holdings as of Jan. 20, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL982gHN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626818724","title":"China SXT Pharmaceuticals prices 2 million-share registered offering for USD 760,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2626818724","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626818724?lang=en_us&edition=fundamental","pubTime":"2026-04-09 21:06","pubTimestamp":1775739971,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals entered securities purchase agreement on April 7, 2026 to sell 2,000,000 Class A ordinary shares.Closing expected April 9, 2026, subject to customary conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL5pMMCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621706107","title":"China SXT Pharmaceuticals, Inc. Announces Share Re-classification","url":"https://stock-news.laohu8.com/highlight/detail?id=2621706107","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621706107?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:00","pubTimestamp":1774270800,"startTime":"0","endTime":"0","summary":"TAIZHOU, China, March  23, 2026 (GLOBE NEWSWIRE) --  China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty pharmaceutical company focusing on the research, development, m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/23/3260426/0/en/China-SXT-Pharmaceuticals-Inc-Announces-Share-Re-classification.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","SXTC","SXT","BK4007","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608887798","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:33 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2608887798","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608887798?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:33","pubTimestamp":1770129208,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:33 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nAQN2LKH0Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sxtchina.com","stockEarnings":[{"period":"1week","weight":-0.974},{"period":"1month","weight":-0.9749},{"period":"3month","weight":-0.9696},{"period":"6month","weight":-0.995},{"period":"1year","weight":-0.9997},{"period":"ytd","weight":-0.9997}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.129972},{"month":2,"riseRate":0.5,"avgChangeRate":-0.09909},{"month":3,"riseRate":0.25,"avgChangeRate":-0.158112},{"month":4,"riseRate":0.125,"avgChangeRate":-0.155346},{"month":5,"riseRate":0,"avgChangeRate":-0.216711},{"month":6,"riseRate":0.75,"avgChangeRate":0.112861},{"month":7,"riseRate":0.125,"avgChangeRate":-0.256094},{"month":8,"riseRate":0,"avgChangeRate":-0.184075},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.131032},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.1238},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.076982},{"month":12,"riseRate":0.571429,"avgChangeRate":0.138689}],"exchange":"NASDAQ","name":"China SXT Pharmaceuticals","nameEN":"China SXT Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"China SXT Pharmaceuticals(SXTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest China SXT Pharmaceuticals(SXTC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"China SXT Pharmaceuticals,SXTC,China SXT Pharmaceuticals股票,China SXT Pharmaceuticals股票老虎,China SXT Pharmaceuticals股票老虎国际,China SXT Pharmaceuticals行情,China SXT Pharmaceuticals股票行情,China SXT Pharmaceuticals股价,China SXT Pharmaceuticals股市,China SXT Pharmaceuticals股票价格,China SXT Pharmaceuticals股票交易,China SXT Pharmaceuticals股票购买,China SXT Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"China SXT Pharmaceuticals(SXTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest China SXT Pharmaceuticals(SXTC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}